NEW YORK, Oct. 9, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that Johns Hopkins ...

At the 2026 ASCO Genitourinary Cancers Symposium, Fred Saad, MD, presented encouraging phase 1 data evaluating the ...

NEW YORK, Nov. 4, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Actinium Pharmaceuticals (ATNM) is a stock that can certainly ...

(RTTNews) - Actinium Pharmaceuticals, Inc. (ATNM) said Tuesday that the independent Data Monitoring Committee or DMC has completed the single ad hoc interim analysis of the pivotal Phase 3 SIERRA ...

Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday after the company announced full data results from the pivotal Phase 3 SIERRA trial in patients with active, relapsed or ...

Key Hires Significantly Strengthen Capabilities in Clinical Operations, Regulatory Affairs, Quality Assurance, Finance and Communications NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc.

Actinium Adds Chief Executive Officer and Chief Financial Officer as Company Prepares for Public Listing of Stock NEW YORK, Aug. 23, 2012 -- /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a ...

Actinium Pharmaceuticals (NYSE:ATNM) traded higher on Tuesday as H.C. Wainwright highlighted its buyout potential after its peer in the radiopharma space, Fusion Pharma (FUSN), agreed to be acquired ...

Opko Health OPK is perhaps most well known at this point for the near daily insider buying by its founder, CEO and Chairman Phillip Frost. A quick look at its insider transaction history paints quite ...